Grisanti Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$7.67M |
| 2 |
Delta Air Lines
DAL
|
+$7.21M |
| 3 |
Valero Energy
VLO
|
+$6.87M |
| 4 |
Becton Dickinson
BDX
|
+$6.21M |
| 5 |
Sherwin-Williams
SHW
|
+$4.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$7.05M |
| 2 |
Centene
CNC
|
+$5.08M |
| 3 |
Cigna
CI
|
+$4.28M |
| 4 |
Wheaton Precious Metals
WPM
|
+$4.24M |
| 5 |
NVIDIA
NVDA
|
+$4.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 24.53% |
| 2 | Financials | 22.94% |
| 3 | Healthcare | 12.04% |
| 4 | Industrials | 11.34% |
| 5 | Energy | 8.48% |
Similar funds
Grisanti Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Grisanti Capital Management held 70 positions worth $183M, up 12% from $164M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Grisanti Capital Management deployed $6.68M of net new capital in Q2 2019, opening 7 new positions and adding to 10 existing holdings. Its largest new stake was Boston Scientific: 199,521 shares worth $8.57M.
By sector, the portfolio is most concentrated in Communication Services at 25% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cigna, an estimated $4.28M trimmed.
- Grisanti Capital Management's largest Q2 2019 buy was Boston Scientific: 199,521 shares worth $8.57M.
- Grisanti Capital Management added most to Wells Fargo in Q2 2019, an estimated $3.55M increase.
- Grisanti Capital Management's biggest Q2 2019 reduction was Cigna, cutting an estimated $4.28M.
- Grisanti Capital Management fully exited DXC Technology in Q2 2019, selling an estimated $7.05M.
- Grisanti Capital Management's ten largest holdings make up 51% of its $183M portfolio in Q2 2019.
- Grisanti Capital Management opened 7 new positions and closed 10 in Q2 2019.
- Grisanti Capital Management's portfolio value rose 12% quarter-over-quarter to $183M.
Based on Grisanti Capital Management's 13F filing for Q2 2019, filed 2 Aug 2019.